Introduction
============

Lung cancer is one of the most common cancers worldwide, with incidence of up to 20.0-44.0 per 100,000 persons in Northern America and Western Europe \[[@b1-crt-2019-057]\]. Mortality rates are high, and the 5-year survival rate is reportedly 10%-20% \[[@b2-crt-2019-057]\]. To decrease such lethal consequences, lung cancer screening using low-dose chest computed tomography (CT) in selected patients has proven to reduce overall mortality \[[@b3-crt-2019-057]\]. Furthermore, such screening has increased the detection of malignant subsolid nodules (SSNs) \[[@b4-crt-2019-057]\]. Such SSNs require regular follow-up because malignancy rates can be even higher for these nodules than for solid nodules \[[@b4-crt-2019-057]\]. Although the risk of recurrence after resection is low for subsolid lung cancer \[[@b5-crt-2019-057]\], the median survival after recurrence is expected to be \< 3 years \[[@b6-crt-2019-057]\]. Thus, identifying risk factors of recurrence is necessary for personalized treatment of patients.

Some factors, such as visceral pleural invasion (VPI), pathological tumor, node, and metastasis staging, lymphovascular invasion, and spread through air space, are associated with postoperative recurrence \[[@b7-crt-2019-057]-[@b9-crt-2019-057]\]. However, most of these factors can only be detected after a surgery is performed, making further resection difficult during surgery. Thus, it would be better if risk evaluation could be based on radiological findings performed before surgery.

SSNs, which are mostly composed of adenocarcinomas, are frequently found in the peripheral lungs. Therefore, the relationship between SSNs and the pleura is noteworthy. Linear pleural tags with soft tissue component at the pleural end on mediastinal window can predict VPI for non-small cell lung cancer (NSCLC) \[[@b10-crt-2019-057]\]. In contrast, studies of subsolid lung cancers have questioned the effect of indentation on VPI, although pleural contact is a significant factor of VPI \[[@b11-crt-2019-057],[@b12-crt-2019-057]\]. The effect of pleura-SSN relationship on VPI, along with the effect on clinical prognoses, is not completely understood.

Therefore, this study aimed to evaluate the effect of pleural attachment and/or indentation on postoperative outcomes, including VPI and recurrence-free survival, in subsolid lung cancers.

Materials and Methods
=====================

1. Study population
-------------------

Patients who underwent lung resection for SSNs from April 2007 to January 2016 in a tertiary referral center were screened. Among them, solitary lung cancer patients and those with surgery of curative intention were selected. Patients were divided into the following four groups based on CT findings before surgery: with or without pleural attachment and/or indentation.

2. Patient assessment, treatment, and follow-up
-----------------------------------------------

Baseline demographics, such as sex, age, smoking status, comorbidities, and pulmonary function test results, were acquired from medical records. The location of lung cancer was identified based on preoperative CT findings. Due to the retrospective nature of the study, the extent of surgery was determined by the attending surgeon. Postoperative adjuvant chemotherapy and/or radiotherapy were performed for high-risk patients with stage IB and IIA lung cancer or for those with pathological stage higher than IIB. After treatment, to detect recurrence, patients were followed up on 3-, 6-, and 12-month intervals using chest CT.

3. Radiographic evaluation
--------------------------

Chest CT was performed using Brilliance 64 and iCT256 (Philips Medical System, Cleveland, OH). CT parameters were 120 kVp and 100-200 mA, and images were reconstructed with a 1-3-mm thickness. All CT scans were obtained with the patient in the supine position at full inspiration, and the latest CT study obtained before surgical resection was selected for analysis. The mediastinal window had a level of 45 Hounsfield units (HUs) and a width of 250 HU, while the lung window had a level of --500 HU and a width of 2,000 HU.

SSNs were classified as nonsolid nodules (NSNs; formerly pure ground glass opacity nodule) if the opacity disappeared on the mediastinal window, and as part-solid nodules (PSNs; formerly mixed ground glass opacity nodule) if it persisted. According to the recent National Comprehensive Cancer Network (NCCN) guidelines, PSNs with solid component ≥ 8 mm are considered to have a higher probability of malignancy and those with solid component ≤ 5 mm are considered to have lower probability. Regarding such recommendation, PSNs were divided into three groups: PSN with solid portion ≤ 5 mm, solid portion \> 5 mm and \< 8 mm, and solid portion ≥ 8 mm. The size of the solid portion was calculated as described in the NCCN guideline, i.e., by averaging the longest longitudinal length and largest diameter perpendicular to it.

Other radiographic findings, such as the longest diameter, distance from the pleura, pleural attachment, and indentation, were assessed in the lung window setting. Distance from the pleura was assessed by drawing a perpendicular line between the pleura and SSN, and the shortest distance was measured. SSN was defined to have a pleural attachment when the distance from the pleura was 0 mm. Pleural indentation was defined as linear areas of high attenuation originating from the SSN extending peripherally to contact the pleura \[[@b13-crt-2019-057],[@b14-crt-2019-057]\]. When SSN was attached to the pleura, any distortions of the pleural architecture by SSN was also defined as pleural indentation and then defined as concurrent pleural attachment with indentation \[[@b12-crt-2019-057]\]. SSNs were divided into four groups according to the relationship with the pleura: neither pleural attachment nor indentation, pleural attachment without indentation, pleural indentation without attachment, and concurrent pleural attachment with indentation. The interpretation of the CT findings was done by an investigator who was not aware of any clinical information. The examples of the four groups are shown in [Fig. 1](#f1-crt-2019-057){ref-type="fig"}.

4. Pathological evaluation
--------------------------

Pathological staging was retrospectively determined according to the eighth edition of the American Joint Committee on Cancer (AJCC) staging system \[[@b15-crt-2019-057]\]. T category was described in eight categories: T1a(mi) to T4; and N category in three categories: N0 to N2. When a lymph node was not evaluated either preoperatively or intraoperatively, it was considered Nx. The overall stage grouping was specified in eight categories (from IA1 to IIIB), in which stage IIIC and IV cancers were not included. Specimens obtained in the early phase of the study were reviewed to allocate them into proper stage according to the AJCC eighth edition. Pathological VPI was considered to be present when invasion beyond the elastic layer was observed \[[@b16-crt-2019-057]\]. Other pathological findings, such as vascular invasion and lymphatic invasion, were also recorded. An investigator blinded from any clinical information participated in the analysis of the pathological findings.

5. Statistical analysis
-----------------------

Baseline demographics and CT, pathological, and clinical findings were organized as numbers (%) for categorical variables using the chi-square test or Fisher's exact test. For continuous variables, Student's t test or Mann-Whitney U test was performed to describe the values in mean± standard variation or median (interquartile range \[IQR\]) according to their patterns of distribution. The pathological stage was grouped as T1, T2, and T3-4 for T category and as I, II, and III for overall stage group to compare the characteristics between patients with or without pleural attachment and/or indentation. Multivariate logistic regression analysis was performed to measure the odds ratios (ORs) and 95% percentile confidence interval (CI) of important radiographic predictors of VPI.

Furthermore, survival analysis was performed with Kaplan-Meier curve with log-rank test and Cox proportional hazards models to evaluate predictors of lung cancer recurrence. Variables with p-values of \< 0.1 were included in the multivariate Cox regression analysis. Hazard ratios (HRs) with 95% CI were calculated.

All statistical analyses were performed using Stata ver. 13.0 (Stata Corp., College Station, TX). p-values \< 0.05 were considered statistically significant.

6. Ethical statement
--------------------

This study was conducted according to the amended Declaration of Helsinki and was approved by the institutional review board of Seoul National University Bundang Hospital (protocol number: B-1604-343-104). Informed consent was waived because of the retrospective design of the study; however, records and information of each patient were anonymized and de-identified before analysis.

Results
=======

1. Patient selection and baseline characteristics
-------------------------------------------------

During the 9-year study period, 541 patients underwent lung resection surgery for SSNs, of whom, patients with multiple primary lung cancer (n=73), benign lesion (n=23), adenocarcinoma *in situ* (n=20), recurred case (n=8), malignancy other than lung cancer (n=5), distant metastasis (n=4), follow-up loss (n=2), N3 disease (n=1), and other coexisting malignancies in the resected specimen (n=1) were excluded. Finally, 404 patients were included. Neither pleural attachment nor indentation was observed in 120 patients (29.7%), pleural attachment without indentation in 26 (6.4%), pleural indentation without attachment in 117 (29.0%), and concurrent pleural attachment with indentation in 141 (34.9%). After surgery, pathological VPI was proven in 36 patients (8.9%). Thirty-four patients (8.4%) experienced lung cancer recurrence at the point of review ([S1 Fig](#SD1-crt-2019-057){ref-type="supplementary-material"}.).

Patients had a fairly even distribution of sex, with a mean age of 62.8 years. Patients without pleural attachment or attachment were younger than others (p=0.015). More than half of the patients (63.3%) were never smokers, with common comorbidities of hypertension (29.2%), diabetes mellitus (13.1%), and other malignancies within 5 years (12.1%). Chronic lung diseases, such as asthma (n=9), bronchiectasis (n=8), and chronic obstructive pulmonary disease (n=3), were observed in 19 patients (4.7%). Subsolid lung cancer was the commonest in the right upper lobe (38.9%), and concurrent pleural attachment with indentation was predominantly observed in the right middle lobe (10.6%). Pleural attachment and/or indentation were observed more frequently among those with PSNs and those with longer diameter. The extent of lung resection was not significantly different among the four groups (p=0.319), with lobectomy being the most common surgery performed (257 patients, 63.4%). Compared to sublobar resection such as wedge resection and segmentectomy, lobectomy was performed in patients with larger solid portion (p \< 0.001), longer longitudinal diameter (median, 24 mm vs. 15 mm; p \< 0.001), and when the SSN was located in right upper lobe or right middle lobe (p \< 0.001). Furthermore, patients who underwent lobectomy revealed higher rates of VPI compared to those of sublobar resection (11.3% vs. 4.8%, p=0.026), along with higher overall pathological stage (p \< 0.001). Adjuvant therapy was performed in 27 of 404 patients (6.7%), which were more frequently performed among those with pleural attachment and indentation (7 among 141 patients, 12.0%) ([Table 1](#t1-crt-2019-057){ref-type="table"}).

2. Radiographic characteristics and pathological correlation
------------------------------------------------------------

Pathology reports of postoperative lung specimen were reviewed. All patients were diagnosed with adenocarcinoma, including invasive adenocarcinoma (n=332, 82.2%) and minimally invasive adenocarcinoma (n=72, 17.8%). VPI was observed in 36 patients (8.9%). SSNs with pleural attachment and indentation had higher association with VPI (31 of 141 patients, 22.0%) than those with attachment alone (1 of 26 patients, 3.9%), indentation alone (4 of 117 patients, 3.4%), and neither (0 of 120 patients, 0.0%) (p \< 0.001). None of the NSNs had VPI, and those with larger solid portion (p \< 0.001) and longer diameter (median, 27 mm vs. 19 mm; p \< 0.001) had a higher probability of VPI ([Table 2](#t2-crt-2019-057){ref-type="table"}). Multivariate logistic regression analysis was performed with meaningful factors associated with VPI. Compared with SSNs with concurrent pleural attachment and indentation, those with attachment only (OR, 0.12; 95% CI, 0.02 to 0.98) and indentation only (OR, 0.10; 95% CI, 0.03 to 0.31) revealed lower odds of VPI ([Table 3](#t3-crt-2019-057){ref-type="table"}).

Pathological staging according to the recent eighth AJCC recommendation was retrospectively performed. The pathological T category was higher among those with pleural attachment and/or indentation. Approximately 31.9% of the pati-ents with concurrent pleural attachment and indentation had at least T2 category, while only two patients (3.4%) with neither pleural attachment nor indentation had T2 category (p \< 0.001). Vascular and lymphatic invasions were also more frequently observed in patients with pleural indentation than in those without it. Although pathological N category (p=0.235) did notreveal statistical difference according to pleural attachment and/or indentation, the overall pathological stage was higher with pleural attachment and indentation (p=0.038) ([S2 Table](#SD2-crt-2019-057){ref-type="supplementary-material"}).

Subgroup analysis of patients with the four different features of SSN-pleura relationship was performed, and the probability of VPI was calculated according to the size of the solid portion in each group. The size of the solid portion largerthan 5 mm was associated with VPI among PSNs with concurrent pleural attachment and indentation (p \< 0.001), while it was not associated with VPI among other groups ([Table 4](#t4-crt-2019-057){ref-type="table"}). Patients with concurrent pleural attachment and indentation, along with solid portion \> 5 mm, were categorized as "high risk of VPI" in the following survival analysis.

3. Differences in clinical outcomes
-----------------------------------

The median follow-up duration for the 404 patients was 48.3 months (IQR, 31.2 to 61.2). Clinical outcomes, such as lung cancer recurrence, and all-cause mortality were compared. Thirty-four patients (8.4%) experienced recurrence within a median of 26.2 months (IQR, 11.7 to 38.5), and 19 patients (4.7%) died in a median of 38.2 months (IQR, 24.4 to 50.1). Concurrent pleural attachment with indentation was associated with higher recurrence (15.6%) and all-cause mortality rate (7.1%) than those without any one of them (3.3% and 0.8%, respectively).

Recurrence-free survival (RFS) was compared with Kaplan-Meier curve and log-rank test, which revealed that concurrent pleural attachment with indentation was associated with shorter time to recurrence in the subsolid lung cancers than in other groups ([Fig. 2](#f2-crt-2019-057){ref-type="fig"}). With multivariate Cox proportional hazards model, smoking history (adjusted HR, 2.20; 95% CI, 1.11 to 4.35), "high risk of VPI" features (adjusted HR, 3.31; 95% CI, 1.58 to 6.91), and longer diameter (adjusted HR, 1.42; 95% CI, 1.21 to 1.67 per cm) were significantly associated with earlier time to recurrence ([S3 Table](#SD3-crt-2019-057){ref-type="supplementary-material"}).

Discussion
==========

In this retrospective cohort study, pleural attachment and/or indentation was observed in more than two-thirds (284 patients) of the 404 patients who underwent curative surgery for subsolid lung cancer. Subsolid lung cancers with pleural attachment and/or indentation were observed in patients with older age and those with larger solid portion and longer diameter. Pleural attachment and/or indentation was not associated with the extent of surgery but was associated with more frequent adjuvant therapies. VPI was not observed in NSNs, while concurrent pleural attachment with indentation was assessed as an independent factor associated with VPI. The size of the solid portion \> 5 mm was associated with higher risk of VPI among patients with concurrent pleural attachment and indentation. Time to lung cancer recurrence was shorter among patients with concurrent pleural attachment and indentation and solid portion \> 5 mm.

In this study, the rates of pleural attachment (41.3%), indentation (63.9%), and VPI (8.9%) were comparable with those reported previously. Pleural attachment was reportedly present in 35.3%-62.2% and indentation in 19.8%-66.4% among subsolid lung adenocarcinomas \[[@b11-crt-2019-057],[@b12-crt-2019-057]\]. The incidence of VPI among nonsolid lung adenocarcinomas is reportedly 0.0%-17.4% and that among part-solid lung adenocarcinoma is 10.0%-32.2% \[[@b7-crt-2019-057],[@b11-crt-2019-057],[@b12-crt-2019-057]\]. We found no VPI among NSNs but found 12.2% of VPI among PSNs.

This is the first study to demonstrate that concurrent pleural attachment with indentation was independently associated with VPI among subsolid lung cancers. Compared to simple attachment of SSN to the pleura, further indentation to the pleura is caused by a combination of two stepwise consequences: contractile change of the cancer and a compensatory enlargement of surrounding tissues to fill the territory between the areas of retracted visceral pleura \[[@b17-crt-2019-057]\]. Therefore, there exists a higher possibility that the cancer invaded the point of tagged visceral pleura. Pleural indentation has been universally considered a positive predictive factor for VPI and lymphovascular invasiveness in NSCLC, including solid cancers \[[@b10-crt-2019-057],[@b18-crt-2019-057]\]. However, considering that chronic lung diseases, such as tuberculosis-destroyed lung, bronchiectasis, and chronic obstructive pulmonary disease, may cause architectural distortion of the lung anatomy, indentation alone may not be relied upon as an independent risk factor for VPI, as shown previously \[[@b11-crt-2019-057]\]. Furthermore, most previous studies were focused on solid lung cancers. Subsolid lung cancers are considered to be less invasive compared to solid tumors and should be examined separately from solid lung cancers \[[@b5-crt-2019-057]\]. The importance of concurrent pleural attachment and indentation was previously suggested in a retrospective study of 194 NSCLC patients \[[@b19-crt-2019-057]\]. Pleural indentation with other additional relationships to the pleura leads to poorer outcomes compared with those with sole indentation.

In a subgroup of subsolid lung cancers with concurrent pleural attachment and indentation, larger solid portion (\> 5 mm) was significantly associated with higher odds of VPI. A larger solid portion was reportedly an independent factor of VPI among PSNs, and NSNs do not show VPI, regardless of their relationship with the pleura \[[@b11-crt-2019-057],[@b20-crt-2019-057],[@b21-crt-2019-057]\]. The relationship with the pleura, presented as concurrent pleural attachment with indentation, should be emphasized as an independent factor for VPI, and if the solid portion is larger, a higher risk of VPI should be suspected.

In our study population, 8.4% of patients experienced recurrence of subsolid lung adenocarcinoma during a median 48.3 months of follow-up. The calculated 5-year RFS was 94.4% for patients with stage IA and 69.3% for those with stage higher stages. The RFS rates of stage IA are comparable with those reported in the previous study of subsolid lung adenocarcinomas \[[@b7-crt-2019-057]\].

VPI is a well-known significant risk factor for recurrence and poor outcomes of NSCLC \[[@b22-crt-2019-057]-[@b24-crt-2019-057]\]. In subsolid lung cancer, however, the effect of VPI on prognosis is still debated. From a retrospective study of 147 subsolid lung cancers without nodal metastasis, VPI was associated with RFS \[[@b7-crt-2019-057]\], but another retrospective study of 466 patients demonstrated similar RFS between the two groups \[[@b25-crt-2019-057]\]. In our study, pathological VPI was an independent factor for earlier recurrence of subsolid lung cancer (adjusted HR, 3.88; 95% CI, 1.84 to 8.15), and "high risk of VPI" feature, defined as concurrent pleural attachment and indentation with solid portion \> 5 mm, was independently associated with earlier recurrence. Pleural indentation is associated with poor outcome among NSCLC \[[@b19-crt-2019-057]\]. Indentation increases the risk of invasion to the visceral pleura, in which lymphatic drainage is abundant, leading to a higher risk of tumor dissemination \[[@b26-crt-2019-057]\]. Pleural attachment is another known factor for locoregional recurrence after radiotherapy in NSCLC and poor survival in lung adenocarcinoma \[[@b27-crt-2019-057],[@b28-crt-2019-057]\]. Therefore, the "high risk of VPI" feature is associated with higher risk of VPI, and it also increases the risk of recurrence, leading to poor prognosis after surgical resection. The recent NCCN guidelines for lung cancer screening and the statement from the Fleischner Society have also emphasized the importance of the size of the solid area \> 5 mm as a higher risk of malignancy among subsolid lung cancers \[[@b29-crt-2019-057]\].

Despite the important findings above, this study had some limitations. First, this was a retrospective study performed at a single center. More studies from different centers are required for generalizability of the results. Second, we did not differentiate pleural invasion beyond the elastic layer (PL1) and invasion to the visceral pleural surface (PL2). Because the discrimination of PL1 and PL2 was performed at our center after September 2012, patients who underwent surgery before that time did not have appropriate pathological reports regarding the two. It must be recognized that prognostic difference may exist between PL1 and PL2 disease \[[@b30-crt-2019-057]\]. Third, the study period was long (9 years). The changing lung cancer staging systems and standards of care may have affected the recurrence rates. Furthermore, the follow-up durations of patients differ according to the time of the operation.

In conclusion, concurrent pleural attachment with indentation of subsolid lung cancer is an independent risk factor for VPI, and the odds of VPI were higher among those with solid portion \> 5 mm. Furthermore, patients with such "high risk of VPI" features experienced earlier recurrence. Therefore, such high-risk findings should be recognized on preoperative CT scans, and earlier surgery could be recommended in these selected patients.
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###### 

Flowchart of patients who underwent curative surgery for subsolid lung adenocarcinoma. CT, computed tomography.

###### 

Pathological findings of subsolid lung adenocarcinomas

###### 

Effect of clinical and radiographic factors on time to recurrence of subsolid lung adenocarcinomas

![Radiographic examples of subsolid nodules. (A, B) Without pleural attachment nor indentation. (C, D) With pleural attachment, but without indentation. (E, F) With indentation, but without pleural attachment. (G, H) With both pleural attachment and indentation.](crt-2019-057f1){#f1-crt-2019-057}

![Effect of pleural attachment and indentation on recurrence-free survival of subsolid lung adenocarcinoma. A, attachment; I, indentation.](crt-2019-057f2){#f2-crt-2019-057}

###### 

Baseline characteristics of 404 patients who underwent curative surgery for subsolid nodule

  Variable                                                                A-- I-- (n=120)   A+ I-- (n=26)   A-- I+ (n=117)   A+ I+ (n=141)   p-value
  ----------------------------------------------------------------------- ----------------- --------------- ---------------- --------------- ----------
  **Male**                                                                56 (46.7)         12 (46.2)       63 (53.9)        56 (39.7)       0.162
  **Age (yr)**                                                            60.3±10.4         63.8±9.3        64.0±10.5        63.8±9.8        0.015
  **Ever smoker**                                                         40 (33.3)         11 (42.3)       50 (42.7)        48 (34.0)       0.364
  **Comorbidity**                                                                                                                            
   Other malignancy in 5 yr                                               15 (12.5)         2 (7.7)         14 (12.0)        18 (12.8)       0.907
   History of tuberculosis                                                2 (1.7)           4 (15.4)        9 (7.7)          4 (2.8)         0.008
   Asthma                                                                 3 (2.5)           0               3 (2.6)          3 (2.1)         \> 0.999
   Bronchiectasis                                                         0                 1 (3.9)         3 (2.6)          4 (2.8)         0.170
   COPD                                                                   0                 0               1 (0.9)          2 (1.4)         0.710
  **Preoperative PFT results**                                                                                                               
   FVC (L)                                                                3.48±0.77         3.07±0.73       3.41±0.89        3.18±0.77       0.005
   FEV~1~ (L)                                                             2.65±0.57         2.39±0.55       2.55±0.74        2.42±0.58       0.018
   FEV~1~ /FVC (%)                                                        76.7±8.2          78.2±5.9        74.9±10.1        76.6±9.2        0.240
  **Location of lung cancer**                                                                                                                
   Right upper lobe                                                       53 (44.2)         6 (23.1)        44 (37.6)        50 (35.5)       0.045
   Right middle lobe                                                      2 (1.7)           1 (3.9)         3 (2.6)          15 (10.6)       
   Right lower lobe                                                       22 (18.3)         6 (23.1)        24 (20.5)        21 (14.9)       
   Left upper lobe                                                        30 (25.0)         6 (23.1)        26 (22.2)        32 (22.7)       
   Left lower lobe                                                        13 (10.8)         7 (26.9)        20 (17.1)        23 (16.3)       
  **Type of subsolid nodule**                                                                                                                
   Nonsolid nodule                                                        61 (50.8)         4 (15.4)        18 (15.4)        26 (18.4)       \< 0.001
   Part-solid nodule                                                                                                                         
    Solid portion ≤ 5 mm                                                  31 (25.8)         3 (11.5)        13 (11.1)        19 (13.5)       
    Solid portion 5-8 mm^[a)](#tfn1-crt-2019-057){ref-type="table-fn"}^   14 (11.7)         3 (11.5)        13 (11.1)        17 (12.1)       
    Solid portion ≥ 5 mm                                                  14 (11.7)         16 (61.5)       73 (62.4)        79 (56.0)       
  **Longest diameter, mm**                                                16.7±5.7          22.7±9.6        23.9±9.7         24.8±14.0       \< 0.001
  **Extent of surgery**                                                                                                                      
   Wedge resection                                                        33 (27.5)         7 (26.9)        20 (17.1)        32 (22.7)       0.319
   Segmentectomy                                                          17 (14.2)         4 (15.4)        20 (17.1)        14 (9.9)        
   Lobectomy                                                              69 (57.5)         15 (57.7)       77 (65.8)        95 (67.4)       
   Pneumonectomy                                                          1 (0.8)           0               0                0               
  **Adjuvant therapy**                                                                                                                       
   None                                                                   118 (98.3)        26 (100)        109 (93.2)       124 (87.9)      0.012
   Chemotherapy                                                           2 (1.7)           0               5 (4.3)          15 (10.6)       
   Concurrent chemo-radiation                                             0                 0               3 (2.6)          2 (1.4)         

Values are presented as number (%) or mean±standard variation. A, attachment; I, indentation; COPD, chronic obstructive pulmonary disease; PFT, pulmonary function test; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.

Excludes 5 and 8 mm.

###### 

Radiographic findings associated with visceral pleural invasion

  Variable                                                                VPI present (n=36)   VPI absent (n=368)   p-value
  ----------------------------------------------------------------------- -------------------- -------------------- ----------
  **Relation with pleura**                                                                                          
   A(--) I(--)                                                            0/120 (0)            120/120 (100)        \< 0.001
   A(+) I(--)                                                             1/26 (3.9)           25/26 (96.2)         
   A(--) I(+)                                                             4/117 (3.4)          113/117 (96.6)       
   A(+) I(+)                                                              31/141 (22.0)        110/141 (78.0)       
  **Type of subsolid nodule**                                                                                       
   Nonsolid nodule                                                        0/109 (0)            109/109 (100)        \< 0.001
   Part-solid nodule                                                                                                
    Solid portion ≤ 5 mm                                                  1/66 (1.5)           65/66 (98.5)         
    Solid portion 5-8 mm^[a)](#tfn2-crt-2019-057){ref-type="table-fn"}^   3/47 (6.4)           44/47 (93.6)         
    Solid portion ≥ 8 mm                                                  32/182 (17.5)        150/182 (82.4)       
  **Longest diameter (mm)**                                               27 (23-40)           19 (14-25)           \< 0.001
  **Location of lung cancer**                                                                                       
   Right upper lobe                                                       10/153 (6.5)         143/153 (93.5)       0.694
   Right middle lobe                                                      3/21 (14.2)          18/21 (85.7)         
   Right lower lobe                                                       7/73 (9.6)           66/73 (90.4)         
   Left upper lobe                                                        10/94 (10.6)         84/94 (89.4)         
   Left lower lobe                                                        6/63 (9.5)           57/63 (90.5)         

Values are presented as number (%). VPI, visceral pleural invasion; A, attachment; I, indentation.

Excludes 5 and 8 mm.

###### 

Radiographic factors associated with visceral pleural invasion in subsolid lung adenocarcinoma

  Variable                                                               OR          95% CI      p-value
  ---------------------------------------------------------------------- ----------- ----------- ----------
  **Relation with pleura**                                                                       
   A(--) I(--)                                                           N/A         N/A         N/A
   A(+) I(--)                                                            0.12        0.02-0.98   0.048
   A(--) I(+)                                                            0.10        0.03-0.31   \< 0.001
   A(+) I(+)                                                             Reference               
  **Size of the solid portion**                                                                  
   Absent solid portion                                                  N/A         N/A         N/A
   Solid portion ≤ 5 mm                                                  0.13        0.02-1.02   0.052
   Solid portion 5-8 mm^[a)](#tfn3-crt-2019-057){ref-type="table-fn"}^   0.44        0.12-1.65   0.221
   Solid portion ≥ 8 mm                                                  Reference               
  **Longest diameter, by cm**                                            1.24        0.93-1.64   0.144

OR, odds ratio; CI, confidence interval; A, attachment; I, indentation; N/A, not applicable.

Excludes 5 and 8 mm.

###### 

Size of the solid portion and visceral pleural invasion according to the pleura-nodule relationship

  Variable                   Solid portion   p-value                                   
  -------------------------- --------------- ------------ ------------- -------------- ----------
  VPI in A(--) I(--) group   0/61 (0)        0/31 (0)     0/14 (0)      0/14 (0)       N/A
  VPI in A(+) I(--) group    0/4 (0)         0/3 (0)      0/3 (0)       1/16 (6.3)     \> 0.999
  VPI in A(--) I(+) group    0/18 (0)        0/13 (0)     0/13 (0)      4/73 (5.5)     0.849
  VPI in A(+) I(+) group     0/26 (0)        1/19 (5.3)   3/17 (17.6)   27/79 (34.1)   \< 0.001

Values are presented as number (%). VPI, visceral pleural invasion; A, attachment; I, indentation; N/A, not available.

Excludes 5 and 8 mm.
